Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Operations (Unaudited)

v2.4.0.6
Consolidated Statements of Operations (Unaudited) (USD $)
 3 Months Ended 6 Months Ended
Jun. 30, 2012
Jun. 30, 2011
Jun. 30, 2012
Jun. 30, 2011
Revenue:        
Product revenues $ 1,000 $ 1,000 $ 2,000 $ 21,000
License revenues 0 0 0 0
TOTAL REVENUE 1,000 1,000 2,000 21,000
Cost of Product Revenue 0 15,000 1,000 40,000
Gross profit (loss) 1,000 (14,000) 1,000 (19,000)
Operating Expenses:        
Research and development 0 28,000 0 49,000
Selling, general and administrative 1,031,000 439,000 1,427,000 2,271,000
Total operating expenses 1,031,000 467,000 1,427,000 2,320,000
Loss from Operations (1,030,000) (481,000) (1,426,000) (2,339,000)
Change in value of warrant and derivative liabilities (212,000) (1,000) (357,000) 102,000
Interest expense/income (1,166,000) (180,000) (1,240,000) (348,000)
Total Other Income (Expense) (1,378,000) (181,000) (1,597,000) (246,000)
Loss before minority interest and provision for income taxes (2,408,000) 0 (3,023,000) 0
Minority interest in subsidiary 13,000 0 13,000 0
Loss before provision for income taxes (2,395,000) (662,000) (3,010,000) (2,585,000)
Provision for income taxes 0 0 0 0
Net loss $ (2,395,000) $ (662,000) $ (3,010,000) $ (2,585,000)
Loss Per Share - basic and diluted $ (0.01) $ 0.00 $ (0.01) $ (0.02)
Weighted Average Shares Outstanding - basic and diluted 329,272,365 182,371,966 306,126,761 167,548,894